Pfizer Inc. has agreed to buy Metsera Inc. in a $10 billion deal, following a tumultuous bidding war with Novo Nordisk A/S ...

Eli Lilly and Company (NYSE:LLY) develops medicines for diabetes, obesity, cancer, autoimmune disorders, and neurological conditions.

NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...

Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer. But major gaps in the ...

Learn more about whether BioMarin Pharmaceutical Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A viral video circulated online in November 2025 that purported to show the United States Secretary of the Department of ...

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

Eli Lilly collaborates with the Trump administration to improve access to GLP-1 receptor agonists for millions of Americans, including those on government programs. The agreement allows Medicare ...

A viral Oval Office incident showing RFK Jr. appearing to “flee” after a man collapsed during Trump’s press conference sparks online debate, prompting White House clarification that he left to get ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...